| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 117.146 | 146.007 | 185.620 | 234.778 | 250.036 | 267.691 | 328.170 | 392.205 | 455.177 | 467.381 |
| Total Income - EUR | 117.149 | 146.008 | 185.644 | 239.268 | 250.671 | 268.173 | 328.191 | 392.207 | 457.427 | 467.385 |
| Total Expenses - EUR | 112.348 | 143.365 | 149.624 | 165.627 | 185.812 | 202.590 | 232.258 | 261.338 | 288.116 | 323.784 |
| Gross Profit/Loss - EUR | 4.801 | 2.643 | 36.020 | 73.640 | 64.859 | 65.582 | 95.932 | 130.869 | 169.311 | 143.601 |
| Net Profit/Loss - EUR | 3.825 | 2.088 | 34.038 | 71.248 | 62.353 | 63.230 | 93.322 | 127.747 | 166.042 | 129.860 |
| Employees | 10 | 10 | 11 | 13 | 13 | 8 | 8 | 8 | 8 | 8 |
Check the financial reports for the company - Poemedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 40.643 | 84.866 | 67.048 | 141.544 | 117.143 | 120.836 | 167.620 | 134.839 | 102.883 | 97.559 |
| Current Assets | 12.452 | 6.518 | 4.383 | 4.439 | 50.574 | 18.508 | 15.839 | 47.083 | 96.865 | 58.635 |
| Inventories | 0 | 0 | 0 | 0 | 3.826 | 6.386 | 7.176 | 2.963 | 5.479 | 5.610 |
| Receivables | 10.206 | 5.192 | 3.481 | 1.941 | 43.150 | 2.199 | 6.092 | 11.523 | 50.192 | 26.694 |
| Cash | 2.246 | 1.327 | 901 | 2.498 | 3.598 | 9.922 | 2.571 | 32.598 | 41.194 | 26.332 |
| Shareholders Funds | 25.259 | 9.186 | 43.068 | 113.525 | 138.937 | 134.839 | 154.269 | 134.210 | 184.897 | 130.978 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 27.836 | 82.199 | 28.363 | 32.458 | 29.147 | 4.833 | 29.489 | 48.112 | 15.129 | 25.379 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Poemedica Srl